As of 2025-08-08, the Relative Valuation of Summit Therapeutics Inc (SMMT) is (3.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 28.07 USD, the upside of Summit Therapeutics Inc based on Relative Valuation is -111.7%.
The range of the Relative Valuation is (2.50) - (4.40) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 18.4x | 13.4x |
| Forward P/E multiples | 10.4x - 20.9x | 14.0x |
| Fair Price | (2.50) - (4.40) | (3.28) |
| Upside | -108.9% - -115.7% | -111.7% |
| Date | P/E |
| 2025-08-05 | -121.65 |
| 2025-08-04 | -122.44 |
| 2025-08-01 | -113.04 |
| 2025-07-31 | -110.12 |
| 2025-07-30 | -111.33 |
| 2025-07-29 | -111.67 |
| 2025-07-28 | -114.63 |
| 2025-07-25 | -119.73 |
| 2025-07-24 | -115.13 |
| 2025-07-23 | -116.97 |
| 2025-07-22 | -110.83 |
| 2025-07-21 | -110.00 |
| 2025-07-18 | -109.41 |
| 2025-07-17 | -115.38 |
| 2025-07-16 | -118.06 |
| 2025-07-15 | -101.73 |
| 2025-07-14 | -106.07 |
| 2025-07-11 | -104.40 |
| 2025-07-10 | -108.08 |
| 2025-07-09 | -103.31 |
| 2025-07-08 | -96.01 |
| 2025-07-07 | -94.42 |
| 2025-07-03 | -102.52 |
| 2025-07-02 | -94.46 |
| 2025-07-01 | -88.53 |
| 2025-06-30 | -88.87 |
| 2025-06-27 | -86.03 |
| 2025-06-26 | -89.03 |
| 2025-06-25 | -88.82 |
| 2025-06-24 | -87.36 |
| 2025-06-23 | -85.15 |
| 2025-06-20 | -85.86 |
| 2025-06-18 | -84.19 |
| 2025-06-17 | -82.89 |
| 2025-06-16 | -83.31 |
| 2025-06-13 | -82.60 |
| 2025-06-12 | -84.19 |
| 2025-06-11 | -81.77 |
| 2025-06-10 | -92.21 |
| 2025-06-09 | -90.03 |
| 2025-06-06 | -85.98 |
| 2025-06-05 | -82.39 |
| 2025-06-04 | -81.68 |
| 2025-06-03 | -86.11 |
| 2025-06-02 | -74.02 |
| 2025-05-30 | -76.07 |
| 2025-05-29 | -109.45 |
| 2025-05-28 | -108.74 |
| 2025-05-27 | -107.07 |
| 2025-05-23 | -107.95 |